{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT05395689",
      "orgStudyIdInfo": {
        "id": "PRO-ACAROS-2018-01"
      },
      "organization": {
        "fullName": "Probelte Pharma S.L.U.",
        "class": "INDUSTRY"
      },
      "briefTitle": "Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM",
      "officialTitle": "Efficacy and Safety Assessment of a Subcutaneous Immunotherapy (Beltavac®) With Polymerized Allergenic Extract From House Dust Mites in Patients With Allergic Rhinitis/Rhinoconjuntivitis",
      "acronym": "PROACAROS"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-07",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2022-01-17",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2026-06",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2026-06",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2022-05-19",
      "studyFirstSubmitQcDate": "2022-05-24",
      "studyFirstPostDateStruct": {
        "date": "2022-05-27",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2024-07-17",
      "lastUpdatePostDateStruct": {
        "date": "2024-07-18",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Probelte Pharma S.L.U.",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The trial is performed to assess efficacy and safety of Beltavac with polymerized extract of house dust mites in allergic Rhinoconjunctivitis associated or not with asthma"
    },
    "conditionsModule": {
      "conditions": [
        "House Dust Mite Allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 350,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Active substance",
          "type": "EXPERIMENTAL",
          "description": "House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae solution administered by the subcutaneous route for 12 months using a rush schedule",
          "interventionNames": [
            "Biological: House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae"
          ]
        },
        {
          "label": "Placebo",
          "type": "PLACEBO_COMPARATOR",
          "description": "Saline solution administered by the subcutaneous route for 12 months using a rush schedule",
          "interventionNames": [
            "Biological: Placebo"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae",
          "description": "The vaccine will be administered according to a rush schedule meaning one administration each month for 1 year",
          "armGroupLabels": [
            "Active substance"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "Placebo",
          "description": "The vaccine will be administered according to a rush schedule meaning one administration each month for 1 year",
          "armGroupLabels": [
            "Placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "The combined nasal symptom and medication score",
          "description": "The symptoms assessed are: itchy nose, sneezing, runny nose, and blocked nose (all rated from 0-3). The medication score is 1 for oral and/or topical antihistamines, 2 for intranasal corticosteroids, and 3 for oral corticosteroids. The scores from the nasal symptoms are added and divided by 4 to a total daily symptom score from 0-3.Final score range from 0 to 6, higher score meaning a worse outcome.",
          "timeFrame": "12 months of treatment"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Score of the nasal symptoms scale",
          "description": "Symptoms assessed are: itchy nose, sneezing, runny nose, and blocked nose (all rated from 0-3). Final score range from 0 to 3, higher score meaning worse outcome.",
          "timeFrame": "12 months of treatment"
        },
        {
          "measure": "Score of the specific medication scale",
          "description": "The medication score is 1 for oral and/or topical antihistamines, 2 for intranasal corticosteroids, and 3 for oral corticosteroids. Final score range from 0 to 3, higher score meaning worse outcome.",
          "timeFrame": "12 months of treatment."
        },
        {
          "measure": "Percentage of days without symptoms or medication",
          "description": "Percentage of days with a zero value for symptom and medication recorded in the patient digital diary",
          "timeFrame": "12 months of treatment"
        },
        {
          "measure": "VAS score (completed by the patient and the investigator)",
          "description": "Visual analogue score from 0 (no symptoms) to 100mm (serious symptoms) to assess global symptoms of allergy",
          "timeFrame": "12 months of treatment."
        },
        {
          "measure": "RCAT questionnaire",
          "description": "Rhinitis Control Assessment Test. Score from 6 (poor control) to 30 (good control)",
          "timeFrame": "12 months of treatment."
        },
        {
          "measure": "Mini-RQLQ questionnaires",
          "description": "Mini-Rhinoconjunctivitis Quality of Life Questionnaire",
          "timeFrame": "12 months of treatment."
        },
        {
          "measure": "Values in serum of specific IgE and IgG4",
          "description": "Specific IgE and IgG4 to DPT and total DF, Der p1 and Der p2, Der p23, Der f1, Der f2",
          "timeFrame": "12 months of treatment."
        },
        {
          "measure": "Number of local and systemic reactions.",
          "description": "Number of local and systemic reaccions associated with the treatment",
          "timeFrame": "13 months of study follow up"
        },
        {
          "measure": "Cost-effectiveness analysis",
          "description": "Number days/ visits related to allergy",
          "timeFrame": "13 months of study follow up"
        },
        {
          "measure": "The combined asthma symptom and medication score",
          "description": "The symptoms assessed are: symptoms during the day, symptoms during the night and physical activity limitations (all rated from 0-3). The medication score is 1 for inhalated corticoids (low dose) , 2 for inhalated corticosteroids associated with LABA, and 3 for inhalated corticosteroids medium dosis associated with LABA. The scores from the symptoms are added and divided by 3 to a total daily symptom score from 0-3. The total daily medication score ranges from 0-3.",
          "timeFrame": "12 months of treatment"
        },
        {
          "measure": "PEF",
          "description": "Peak expiratory flow measured with a Smart Peak Flow device",
          "timeFrame": "12 months of treatment"
        },
        {
          "measure": "ACT questionnaire",
          "description": "Asthma Control Test Questionnaire to assess the control of asthma in asthmatic patients",
          "timeFrame": "12 months of treatment"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Written informed consent, signed and duly dated.\n* Man or woman between 12 and 65 years old (both included).\n* Patient with moderate or severe symptoms of persistent rhinitis according to the ARIA Guide, associated or not with well or partially controlled asthma according to the GEMA 5.0 Guide.\n* Confirmation of sensitization to DPT or DF with a positive prick test (mean papule diameter greater than or equal to 3 mm) with a commercial standardized allergenic extract and a serum extract-specific IgE value of class 3 or higher (\\> 3.5 kU / L) within the 6 months prior to the study.\n* Negative pregnancy test.\n* Nasal symptom and medication combined scale score ≥ 1.5 during the screening phase.\n\nExclusion Criteria:\n\n* Concomitant sensitization to allergens other than dust mites if clinically relevant symptoms are anticipated that may interfere with study evaluation periods at the discretion of the investigator.\n* Poorly controlled asthma according to the GEMA 5.0 guideline\n* Severe asthma, that is, those who during the last months have controlled their asthma according to therapeutic step 5-6 of the GEMA 5.0 guideline.\n* Autoimmune diseases or immunodeficiency.\n* Malignant neoplasms, serious cardiovascular disease, serious mental illness or other relevant chronic diseases that may interfere with the results of the study.\n* Clinical history of anaphylaxis with cardio / respiratory symptoms.\n* Hypersensitivity to any of the excipients of the investigational product.\n* Immunosuppressive medication during the last 6 months before the inclusion of patients and until the end of the study.\n* Treatment with beta-blockers during the study.\n* Patients who have previously received immunotherapy with allergenic dust mite extract or other extracts and have failed within the last 5 years.\n* Patients with immunotherapy with allergens other than dust mites during the study period.\n* Patients who receive any other vaccine one week before the start of treatment or awaiting the second dose of vaccine against COVID-19.\n* Pregnant or nursing patients.",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "12 Years",
      "maximumAge": "65 Years",
      "stdAges": [
        "CHILD",
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "Inma Buendia",
          "role": "CONTACT",
          "phone": "+34 608 933 618",
          "email": "inmaculadabuendia@probeltepharma.es"
        }
      ],
      "locations": [
        {
          "facility": "Hospital Vega Baja",
          "status": "RECRUITING",
          "city": "Orihuela",
          "state": "Alicante",
          "country": "Spain",
          "contacts": [
            {
              "name": "Angel Ferrer",
              "role": "CONTACT"
            },
            {
              "name": "Angel Ferrer",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 38.08483,
            "lon": -0.94401
          }
        },
        {
          "facility": "Hospital General de Granollers",
          "status": "RECRUITING",
          "city": "Granollers",
          "state": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Patricia Martinez Lezcano, MD",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.60797,
            "lon": 2.28773
          }
        },
        {
          "facility": "Hospital de Canarias",
          "status": "WITHDRAWN",
          "city": "Santa Cruz de Tenerife",
          "state": "Canary Islands",
          "country": "Spain",
          "geoPoint": {
            "lat": 28.46824,
            "lon": -16.25462
          }
        },
        {
          "facility": "Hospital de la Plana",
          "status": "RECRUITING",
          "city": "Castellon",
          "state": "Castellón",
          "country": "Spain",
          "contacts": [
            {
              "name": "David El Qutob, MD",
              "role": "CONTACT"
            },
            {
              "name": "David El -Qutob, MD",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.98567,
            "lon": -0.04935
          }
        },
        {
          "facility": "Hospital Regional de Málaga",
          "status": "RECRUITING",
          "city": "Málaga",
          "state": "Málaga",
          "country": "Spain",
          "contacts": [
            {
              "name": "M J Torres",
              "role": "CONTACT"
            },
            {
              "name": "M J Torres, MD",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Complejo Hospitalario de Navarra",
          "status": "RECRUITING",
          "city": "Pamplona",
          "state": "Navarre",
          "country": "Spain",
          "contacts": [
            {
              "name": "Ana Tabar Purroy, MD",
              "role": "CONTACT"
            },
            {
              "name": "Ana Tabar Purroy",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 42.81687,
            "lon": -1.64323
          }
        },
        {
          "facility": "Fundacion Sanitaria Sant Pere Claver",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Helena Hermida, MD",
              "role": "CONTACT"
            },
            {
              "name": "Helena Hermida, MD",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital de Bellvitge",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Teresa Dordal, MD",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Germans Trias i Pujol",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Albert Roger, MD",
              "role": "CONTACT"
            },
            {
              "name": "Albert Roger",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital infantil Vall d Hebron",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Teresa Garriga, MD",
              "role": "CONTACT"
            },
            {
              "name": "Teresa Garriga",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Val d ' Hebron",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Victoria Cardona, MD",
              "role": "CONTACT"
            },
            {
              "name": "Victoria Cardona, MD",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital General de Castellón",
          "status": "RECRUITING",
          "city": "Castelló",
          "country": "Spain",
          "contacts": [
            {
              "name": "J.V. Castelló Carrascosa",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.01149,
            "lon": 0.84856
          }
        },
        {
          "facility": "Hospital Virgen de la Arrixaca",
          "status": "WITHDRAWN",
          "city": "Murcia",
          "country": "Spain",
          "geoPoint": {
            "lat": 37.98704,
            "lon": -1.13004
          }
        },
        {
          "facility": "Hospital de Fatima",
          "status": "RECRUITING",
          "city": "Seville",
          "country": "Spain",
          "contacts": [
            {
              "name": "J.L. Pérez Formoso",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Hospital Virgen Macarena",
          "status": "RECRUITING",
          "city": "Seville",
          "country": "Spain",
          "contacts": [
            {
              "name": "Pilar Lara de la Rosa",
              "role": "CONTACT"
            },
            {
              "name": "Pilar Lara de la Rosa",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Hospital Clinico Universitario de Valencia",
          "status": "RECRUITING",
          "city": "Valencia",
          "country": "Spain",
          "contacts": [
            {
              "name": "Enrique Burches, MD",
              "role": "CONTACT"
            },
            {
              "name": "Enrique Burches",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        },
        {
          "facility": "Hospital Politecnico de la Fé",
          "status": "RECRUITING",
          "city": "Valencia",
          "country": "Spain",
          "contacts": [
            {
              "name": "Miguel Angel Diaz, MD",
              "role": "CONTACT"
            },
            {
              "name": "Miguel Angel Diaz, MD",
              "role": "PRINCIPAL_INVESTIGATOR"
            }
          ],
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        },
        {
          "facility": "Hospital Universitario Infantil de la Fé",
          "status": "RECRUITING",
          "city": "Valencia",
          "country": "Spain",
          "contacts": [
            {
              "name": "Miguel Tortajada, MD",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 39.47391,
            "lon": -0.37966
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D000092542",
          "term": "Dust Mite Allergy"
        }
      ],
      "ancestors": [
        {
          "id": "D012221",
          "term": "Rhinitis, Allergic, Perennial"
        },
        {
          "id": "D065631",
          "term": "Rhinitis, Allergic"
        },
        {
          "id": "D012220",
          "term": "Rhinitis"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D039741",
          "term": "Antigens, Dermatophagoides"
        }
      ],
      "ancestors": [
        {
          "id": "D000941",
          "term": "Antigens"
        },
        {
          "id": "D001685",
          "term": "Biological Factors"
        }
      ]
    }
  },
  "hasResults": false
}